More articles from Volume 31, Issue 1, 2003
EFFECTS OF GLUCAGON ON HEMODINAMIC VARIABLES IN CONDITIONS ON BLOCADE BETA ADRENORECEPTORS
IMPORTANCE OF AFP AND CEA DETERMINATION IN EXPERIMENTALY INDUCED GLIOMA
ANTIPYRETICAL EFFECT OF PARSLEY EXTRACTS (Petroselinum crispum L.) AT MICE
NEUROLOGICAL DEVELOPMENT OF HIGH-RISK NEWBORN INFANTS IN THE FIRST THREE YEARS OF LIFE
ESSENTIAL CHARACTERISTICS OF REPEATED MYOCARDIAL INFARCTION
COMPARATIVE EFFECT OF ORAL ESTROGEN REPLACEMENT THERAPY ON LIPID LEVELS AND LEFT VENTRICULAR FUNCTION IN POSTMENOPAUZAL WOMEN SMOKERS AND NON-SMOKERS
University Hospital "Zvezdara", Belgrade, Serbia
University Hospital "Bezanijska kosa", Belgrade, Serbia
University Hospital "Bezanijska kosa", Belgrade, Serbia
University Hospital "Zvezdara", Belgrade, Serbia
Medical faculty, University of Belgrade, Belgrade, Serbia
Medical faculty, University of Belgrade, Belgrade, Serbia
Published: 01.01.2003.
Volume 31, Issue 1 (2003)
pp. 37-41;
Abstract
Menopause may influence negatively the cardiovascular system of women, especially that of smokers. The aim of
our study was to compare lipid levels and left ventricular function in postmenopausal women smokers and non-smokers
during 12 months of oral estrogen replacement therapy. The study group included healthy postmenopausal women, 30
smokers and 32 non-smokers. Before and in 6 month intervals the following parameters were followed: total cholesterol,
LDL-, HDL-cholesterol, triglycerides, blood pressure and echocardiographic parameters of systolic and diastolic left
ventricular function. Before therapy non-smokers had higher total and LDL-cholesterol, when compared to smokers. Oral
estrogen replacement therapy significantly decreased levels of total and LDL-cholesterol and increased HDL-cholesterol,
only in non-smokers. No change in lipid levels was observed in smokers. However, women who smoked longer had higher
triglyceride levels after 12 months of oral estrogen replacement therapy. Echocardiography revealed significant improvement of systolic and diastolic left ventricular function in non-smokers, while improvement of only systolic function in
smokers. Our study has shown that 12 months of oral estrogen replacement therapy may not have a protective role on the
cardiovascular system of postmenopausal women smokers
Keywords
References
Citation
Copyright
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Article metrics
The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.
